Clinical Trial: A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07544030) titled 'A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer' on March 21.

Brief Summary: Evaluation Compared with traditional NACT, whether PIPAC can increase the incidence of CRS3 determines the rationality of choosing PIPAC.

Study Start Date: Nov. 10, 2025

Study Type: INTERVENTIONAL

Condition: Ovarian Cancer

Intervention: PROCEDURE: PIPAC

This is a randomized, controlled, open, and parallel design clinical study aimed at evaluating the efficacy and safety of PIPAC. Sixty patients with stage IIIC-IVA high-...